- Q1 2024 Lucid Diagnostics Inc Earnings Call TranscriptMay 13, 2024$0.95 (+0.59%)Earnings
- Q4 2023 Lucid Diagnostics Inc Earnings Call TranscriptMar 26, 2024$0.99 (-6.60%)Earnings
- Q3 2023 Lucid Diagnostics Inc Earnings Call TranscriptNov 14, 2023$1.3 (+12.07%)Earnings
- Q2 2023 Lucid Diagnostics Inc Earnings Call TranscriptAug 15, 2023$1.49 (+0.34%)Earnings
- Lucid Diagnostics Inc Annual Shareholders Meeting TranscriptJun 21, 2023
- Q4 2022 Lucid Diagnostics Inc Earnings Call TranscriptMar 14, 2023$1.72 (+6.83%)Earnings
- PAVmed Inc, Lucid Diagnostics Inc and Veris Health Inc Strategic Business Update Call TranscriptJan 17, 2023
- Q3 2022 Lucid Diagnostics Inc Earnings Call TranscriptNov 14, 2022$2.27 (+1.79%)Earnings
- Q2 2022 Lucid Diagnostics Inc Earnings Call TranscriptAug 15, 2022$3.35 (-1.18%)Earnings
- Lucid Diagnostics Inc Annual Shareholders Meeting TranscriptJun 21, 2022
- Q1 2022 Lucid Diagnostics Inc Earnings Call TranscriptMay 11, 2022$1.86 (-7.46%)Earnings
- Lucid Diagnostics Inc at Needham Healthcare Conference (Virtual) TranscriptApr 12, 2022
PAVmed Inc, Lucid Diagnostics Inc and Veris Health Inc Strategic Business Update Call Transcript
Greetings, and welcome to the PAVmed and Lucid Diagnostics Strategic Business Update. (Operator Instructions) As a reminder, this conference is being recorded. It is now my pleasure to introduce your host, Michael Parks, Vice President of Investor Relations. Thank you. You may begin.
Thank you, Doug. Good afternoon, everyone. Thank you for participating in today's joint business update call. The press release announcing our strategic business update is available on both PAVmed and Lucid websites. Please take a moment to read the disclaimer about forward-looking statements in the press release. The strategic business update, press release and the conference call, those include forward-looking statements, and these forward-looking statements are subject to known and unknown risks and uncertainties that may cause actual results to differ materially from statements made. Factors that could cause actual results to differ are described in the disclaimer and in our filings with the SEC. For a list and description of these and other important risks and
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)